lobbying_activities: 2026206
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026206 | 7b334589-2757-4ea5-8194-3a0e82f15eb4 | Q3 | WAXMAN STRATEGIES | 401103693 | 340B HEALTH | 2017 | third_quarter | PHA | Issues affecting the 340B drug pricing program | HOUSE OF REPRESENTATIVES | 18750 | 0 | 0 | 2017-10-17T09:12:29.677000-04:00 |